4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

890.00p
   
  • Change Today:
    -10.00p
  • 52 Week High: 1,500.00p
  • 52 Week Low: 870.00p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 804
  • Market Cap: £138.29m
  • Beta: 0.03

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

Key Personnel

CEO: Heikki Lanckriet
CFO: David John Roth
Chief Operating Officer: Amy Walker
Executive Chairman: Manja Hermina Elisabeth Maria Boerman
Independent Non-Executive Director: Alan Malus
Independent Non-Executive Director: Maria Del Pilar de la Huerta
Non-Executive Dir: Joseph Manuel Fernández, Hansjörg Plaggemars

Contact Details

Address: 25 Norman Way, Over, Cambridge, United Kingdom, CB24 5QE
Phone: +44 (0)1223 967943
Website: http://www.4basebio.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BMCLYF79

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 890.00p
Change Today -10.00p
% Change -1.11 %
52 Week High 1,500.00p
52 Week Low 870.00p
Volume 804
Shares Issued 15.54m
Market Cap £138.29m
Beta 0.03

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average65.49% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Price Trend
34.14% below the market average34.14% below the market average34.14% below the market average34.14% below the market average34.14% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Income Not Available
Growth
59.30% above the market average59.30% above the market average59.30% above the market average59.30% above the market average59.30% above the market average
65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average65.52% above the sector average

4basebio Dividends

No dividends found

Trades for 18-Aug-2025

Time Volume / Share Price
15:52 0 @ 930.00p
15:52 345 @ 870.00p
15:40 459 @ 870.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page